Global Alfentanil Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Alfentanil Market Research Report 2024
Alfentanil is a potent but short-acting synthetic opioid analgesic drug, used for anaesthesia in surgery. It is an analogue of fentanyl with around 1/4 to 1/10 the potency of fentanyl and around 1/3 of the duration of action, but with an onset of effects 4x faster than fentanyl. Alfentanil has a pKa of approximately 6.5, which leads to a very high proportion of the drug being uncharged at physiologic pH. This unique characteristic is responsible for its rapid onset. It is an agonist at mu opioid receptors
According to Mr Accuracy reports’s new survey, global Alfentanil market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Alfentanil market research.
Key manufacturers engaged in the Alfentanil industry include Akorn, Pfizer, Hameln Pharmaceuticals, JV Healthcare, Novartis, Angelini Pharma, Johnson & Johnson, CristÁLia and Auden Mckenzie, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Alfentanil were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Alfentanil market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alfentanil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Akorn
Pfizer
Hameln Pharmaceuticals
JV Healthcare
Novartis
Angelini Pharma
Johnson & Johnson
CristÁLia
Auden Mckenzie
Horizon Hospital Healthcare
Algol Pharma
Max Health
Segment by Type
Intravenous
Subcutaneous
Perioperative Analgesia
Adjunct to General Anesthesia
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Alfentanil report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Alfentanil market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Alfentanil market research.
Key manufacturers engaged in the Alfentanil industry include Akorn, Pfizer, Hameln Pharmaceuticals, JV Healthcare, Novartis, Angelini Pharma, Johnson & Johnson, CristÁLia and Auden Mckenzie, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Alfentanil were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Alfentanil market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Alfentanil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Akorn
Pfizer
Hameln Pharmaceuticals
JV Healthcare
Novartis
Angelini Pharma
Johnson & Johnson
CristÁLia
Auden Mckenzie
Horizon Hospital Healthcare
Algol Pharma
Max Health
Segment by Type
Intravenous
Subcutaneous
Segment by Application
Perioperative Analgesia
Adjunct to General Anesthesia
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Alfentanil report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source